{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:17:02Z","timestamp":1778779022197,"version":"3.51.4"},"reference-count":26,"publisher":"IOP Publishing","issue":"6","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"crossref","award":["R01EB022075"],"award-info":[{"award-number":["R01EB022075"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Phys. Med. Biol."],"published-print":{"date-parts":[[2023,3,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Objective<\/jats:italic>\n                    .\n                    <jats:sup>90<\/jats:sup>\n                    Y selective internal radiation therapy (SIRT) treatment of hepatocellular carcinoma (HCC) can potentially underdose lesions, as identified on post-therapy PET\/CT imaging. This study introduces a methodology and explores the feasibility for selectively treating SIRT-underdosed HCC lesions, or lesion subvolumes, with stereotactic body radiation therapy (SBRT) following post-SIRT dosimetry.\n                    <jats:italic>Approach<\/jats:italic>\n                    . We retrospectively analyzed post-treatment PET\/CT images of 20 HCC patients after\n                    <jats:sup>90<\/jats:sup>\n                    Y SIRT. Predicted tumor response from SIRT was quantified based on personalized post-therapy dosimetry and corresponding response models. Predicted non-responding tumor regions were then targeted with a hypothetical SBRT boost plan using a framework for selecting eligible tumors and tumor subregions. SBRT boost plans were compared to SBRT plans targeting all tumors irrespective of SIRT dose with the same prescription and organ-at-risk (OAR) objectives. The potential benefit of SIRT followed by a SBRT was evaluated based on OAR dose and predicted toxicity compared to the independent SBRT treatment.\n                    <jats:italic>Main results<\/jats:italic>\n                    . Following SIRT, 14\/20 patients had at least one predicted non-responding tumor considered eligible for a SBRT boost. When comparing SBRT plans, 10\/14 (71%) SBRT\n                    <jats:sub>boost<\/jats:sub>\n                    and 12\/20 (60%) SBRT\n                    <jats:sub>alone<\/jats:sub>\n                    plans were within OAR dose constraints. For three patients, SBRT\n                    <jats:sub>boost<\/jats:sub>\n                    plans were within OAR constraints while SBRT\n                    <jats:sub>alone<\/jats:sub>\n                    plans were not. Across the 14 eligible patients, SBRT\n                    <jats:sub>boost<\/jats:sub>\n                    plans had significantly less dose to the healthy liver (decrease in mean dose was on average \u00b1 standard deviation, 2.09 Gy \u00b1 1.99 Gy, ) and reduced the overall targeted PTV volume (39% \u00b1 21%) compared with SBRT\n                    <jats:sub>alone<\/jats:sub>\n                    .\n                    <jats:italic>Significance<\/jats:italic>\n                    . A clinical methodology for treating HCC using a synergized SIRT and SBRT approach is presented, demonstrating that it could reduce normal tissue toxicity risk in a majority of our retrospectively evaluated cases. Selectively targeting SIRT underdosed HCC lesions, or lesion subvolumes, with SBRT could improve tumor control and patient outcomes post-SIRT and allow SIRT to function as a target debulking tool for cases when SBRT is not independently feasible.\n                  <\/jats:p>","DOI":"10.1088\/1361-6560\/acbbb5","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T17:36:08Z","timestamp":1676309768000},"page":"065003","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Stereotactic body radiation therapy (SBRT) following Yttrium-90 (\n                    <sup>90<\/sup>\n                    Y) selective internal radiation therapy (SIRT): a feasibility planning study using\n                    <sup>90<\/sup>\n                    Y delivered dose"],"prefix":"10.1088","volume":"68","author":[{"given":"Stephen F","family":"Mee","sequence":"first","affiliation":[{"name":"University of Michigan"},{"name":"Wayne State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8182-8832","authenticated-orcid":false,"given":"Daniel F","family":"Polan","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuni K","family":"Dewaraja","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle C","family":"Cuneo","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J","family":"Gemmete","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R","family":"Evans","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore S","family":"Lawrence","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janell S","family":"Dow","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin K","family":"Mikell","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"pmbacbbb5bib1","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.11.002","type":"journal-article","article-title":"Stereotactic inverse dose planning after Yttrium-90 selective internal radiation therapy in hepatocellular cancer","volume":"6","author":"Abbott","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"pmbacbbb5bib2","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.100948","type":"journal-article","article-title":"Clinical outcomes of patients with unresectable primary liver cancer treated with yttrium-90 radioembolization with an escalated dose","volume":"7","author":"Chin","year":"2022","journal-title":"Adv. Radiat. Oncol."},{"key":"pmbacbbb5bib3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13550-022-00911-0","type":"journal-article","article-title":"TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity","volume":"12","author":"d\u2019Abadie","year":"2022","journal-title":"EJNMMI Res."},{"key":"pmbacbbb5bib4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1080\/02841860600936369","type":"journal-article","article-title":"Individualized image guided iso-NTCP based liver cancer SBRT","volume":"45","author":"Dawson","year":"2006","journal-title":"Acta Oncol."},{"key":"pmbacbbb5bib5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.semradonc.2005.04.005","type":"journal-article","article-title":"Partial volume tolerance of the liver to radiation","volume":"15","author":"Dawson","year":"2005","journal-title":"Semin. Radiat. Oncol."},{"key":"pmbacbbb5bib6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2967\/jnumed.119.226472","type":"journal-article","article-title":"Prediction of tumor control in 90Y radioembolization by logit models with PET\/CT based dose metrics","volume":"61","author":"Dewaraja","year":"2020","journal-title":"J. Nucl. Med."},{"key":"pmbacbbb5bib7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2967\/jnumed.111.094235","type":"journal-article","article-title":"Dosimetry based on 99mTc-macroaggregated albumin SPECT\/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results","volume":"53","author":"Garin","year":"2012","journal-title":"J. Nucl. Med."},{"key":"pmbacbbb5bib8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","type":"journal-article","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"pmbacbbb5bib9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4251\/wjgo.v11.i5.367","type":"journal-article","article-title":"Stereotactic body radiation therapy in patients with hepatocellular carcinoma: a mini-review","volume":"11","author":"Gerum","year":"2019","journal-title":"World J. Gastrointest. Oncol."},{"key":"pmbacbbb5bib10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00259-011-1812-2","type":"journal-article","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"38","author":"Giammarile","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"pmbacbbb5bib11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264458","type":"journal-article","article-title":"A multicenter study on observed discrepancies between vendor-stated and PET measured 90Y activities for both glass and resin microsphere devices [published online ahead of print","volume":"64","author":"Gnesin","year":"2022","journal-title":"J. Nucl. Med."},{"key":"pmbacbbb5bib12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40658-022-00447-1","type":"journal-article","article-title":"Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model","volume":"9","author":"Henry","year":"2022","journal-title":"EJNMMI Phys."},{"key":"pmbacbbb5bib13","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijrobp.2020.11.008","type":"journal-article","article-title":"Long-Term Results of NRG Oncology\/RTOG 0321: A phase II trial of combined high dose rate brachytherapy and external beam radiation therapy for adenocarcinoma of the prostate","volume":"110","author":"Hsu","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbacbbb5bib14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/cncr.32502","type":"journal-article","article-title":"A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy","volume":"126","author":"Jang","year":"2020","journal-title":"Cancer."},{"key":"pmbacbbb5bib15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijrobp.2018.05.062","type":"journal-article","article-title":"Hepatocellular carcinoma tumor dose response after 90Y-radioembolization with glass microspheres using 90Y-SPECT\/CT-based voxel dosimetry","volume":"102","author":"Kappadath","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbacbbb5bib16","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1038\/emm.2017.85","type":"journal-article","article-title":"Radiation-induced liver disease: current understanding and future perspectives","volume":"49","author":"Kim","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"pmbacbbb5bib17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3857\/roj.2021.00213","type":"journal-article","article-title":"Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis","volume":"39","author":"Liu","year":"2021","journal-title":"Radiat. Oncol. J."},{"key":"pmbacbbb5bib18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ijrobp.2019.04.012","type":"journal-article","article-title":"Assessing Spatial Concordance Between Theranostic Pairs Using Phantom and Patient-Specific Acceptance Criteria: Application to 99mTc-MAA SPECT\/90Y-Microsphere PET","volume":"104","author":"Mikell","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbacbbb5bib19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.21037\/jgo.2015.10.04","type":"journal-article","article-title":"Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma","volume":"7","author":"Oladeru","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"pmbacbbb5bib20","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","type":"journal-article","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbacbbb5bib21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jhep.2019.08.006","type":"journal-article","article-title":"Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma","volume":"71","author":"Ricke","year":"2019","journal-title":"J. Hepatol."},{"key":"pmbacbbb5bib22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/jcm8010055","type":"journal-article","article-title":"History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma","volume":"8","author":"Saini","year":"2019","journal-title":"J. Clin. Med."},{"key":"pmbacbbb5bib23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","type":"journal-article","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"pmbacbbb5bib24","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","type":"journal-article","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol."},{"key":"pmbacbbb5bib25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1109\/TNS.2006.889164","type":"journal-article","article-title":"Method for fast CT\/SPECT-Based 3D Monte Carlo absorbed dose computations in internal emitter therapy","volume":"54","author":"Wilderman","year":"2007","journal-title":"IEEE Trans. Nucl. Sci."},{"key":"pmbacbbb5bib26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13550-017-0292-1","type":"journal-article","article-title":"Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis","volume":"7","author":"Willowson","year":"2017","journal-title":"EJNMMI Res."}],"container-title":["Physics in Medicine &amp; Biology"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:00:22Z","timestamp":1778778022000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/acbbb5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3,10]]},"published-print":{"date-parts":[[2023,3,21]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6560\/acbbb5","relation":{},"ISSN":["0031-9155","1361-6560"],"issn-type":[{"value":"0031-9155","type":"print"},{"value":"1361-6560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"Stereotactic body radiation therapy (SBRT) following Yttrium-90 (\n                      90\n                      Y) selective internal radiation therapy (SIRT): a feasibility planning study using\n                      90\n                      Y delivered dose","name":"article_title","label":"Article Title"},{"value":"Physics in Medicine & Biology","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2023 The Author(s). Published on behalf of Institute of Physics and Engineering in Medicine by IOP Publishing Ltd","name":"copyright_information","label":"Copyright Information"},{"value":"2022-10-04","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2023-02-13","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2023-03-10","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}